Your browser doesn't support javascript.
loading
Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis.
Endre, Zoltán H; Pickering, John W.
Affiliation
  • Endre ZH; Department of Nephrology, Prince of Wales Hospital and Clinical School, University of New South Wales, High Street, Randwick, Sydney, NSW 2031, Australia.
  • Pickering JW; Department of Medicine, University of Otago-Christchurch, and the Emergency Care Foundation, Christchurch Hospital, Riccarton Avenue, Christchurch 8140, New Zealand.
Nat Rev Nephrol ; 10(12): 683-5, 2014 12.
Article in En | MEDLINE | ID: mdl-25347946
FDA approval of the first device to use novel biomarkers of kidney damage to assess risk of acute kidney injury (AKI) potentially brings forward diagnosis of moderate-to-severe AKI to a time frame that could enable early intervention. Although the device awaits greater scrutiny, its approval marks the beginning of a new era.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor Binding Proteins / Matrix Metalloproteinase 2 / Early Diagnosis / Acute Kidney Injury / Cell Cycle Checkpoints Type of study: Diagnostic_studies / Screening_studies Aspects: Determinantes_sociais_saude Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Nat Rev Nephrol Journal subject: NEFROLOGIA Year: 2014 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor Binding Proteins / Matrix Metalloproteinase 2 / Early Diagnosis / Acute Kidney Injury / Cell Cycle Checkpoints Type of study: Diagnostic_studies / Screening_studies Aspects: Determinantes_sociais_saude Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Nat Rev Nephrol Journal subject: NEFROLOGIA Year: 2014 Document type: Article Affiliation country: Australia Country of publication: United kingdom